Patents by Inventor Liat Flaishon

Liat Flaishon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND REGIMENS FOR THE TREATMENT OF HEMATOLOGICAL CANCER
    Publication number: 20230158055
    Abstract: The invention provides methods and uses for the treatment of hematological cancer in a subject in need thereof.
    Type: Application
    Filed: April 22, 2021
    Publication date: May 25, 2023
    Applicant: Biosight Ltd.
    Inventors: Liat FLAISHON, Ruth BEN YAKAR
  • COMBINATION CANCER THERAPY
    Publication number: 20200147117
    Abstract: The present invention relates to combination therapies of a cytarabine conjugate and one or more anti-neoplastic agents for inhibiting cancer cell growth. In particular, the present invention relates to a conjugate of cytarabine and aspartic acid (BST-236) in combination with one or more additional anti-neoplastic agents for use in the treatment of hematological cancers.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 14, 2020
    Applicant: BIOSIGHT LTD.
    Inventors: Ruth BEN YAKAR, Stela Gengrinovitch, Shoshi Tessler, Liat Flaishon
  • PHARMACEUTICAL COMPOSITIONS COMPRISING CCL2 AND USE OF SAME FOR THE TREATMENT OF INFLAMMATION
    Publication number: 20110165116
    Abstract: A method of treating an inflammation in a subject thereof is provided. The method comprising administering to the subject a therapeutically effective amount of CCL2, thereby treating the inflammation. Also provided are pharmaceutical compositions and unit dosage forms which comprise CCL2 for the treatment of inflammation.
    Type: Application
    Filed: March 17, 2011
    Publication date: July 7, 2011
    Applicant: Yeda Research And Development Co., Ltd.
    Inventors: Liat FLAISHON, Idit Shachar
  • Pharmaceutical compositions comprising CCL2 and use of same for the treatment of inflammation
    Patent number: 7919077
    Abstract: A method of treating an inflammation in a subject thereof is provided. The method comprising administering to the subject a therapeutically effective amount of CCL2, thereby treating the inflammation. Also provided are pharmaceutical compositions and unit dosage forms which comprise CCL2 for the treatment of inflammation.
    Type: Grant
    Filed: June 28, 2007
    Date of Patent: April 5, 2011
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Liat Flaishon, Idit Shachar
  • Pharmaceutical Compositions Comprising Ccl2 and Use of Same For The Treatment of Inflammation
    Publication number: 20090239799
    Abstract: A method of treating an inflammation in a subject thereof is provided. The method comprising administering to the subject a therapeutically effective amount of CCL2, thereby treating the inflammation. Also provided are pharmaceutical compositions and unit dosage forms which comprise CCL2 for the treatment of inflammation.
    Type: Application
    Filed: June 28, 2007
    Publication date: September 24, 2009
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
    Inventors: Liat Flaishon, Idit Shachar
  • Method and pharmaceutical composition for treating inflammation
    Publication number: 20080145337
    Abstract: A method of treating an inflammation in a subject in need thereof is disclosed. The method comprises locally or systemically administering to the subject IFN-gamma in an amount so as to achieve an IFN-gamma bulk tissue concentration at a site of inflammation of 1-8,000 units per kilogram body weight, thereby ameliorating the inflammation.
    Type: Application
    Filed: February 19, 2008
    Publication date: June 19, 2008
    Applicant: Yeda Research And Development Co. Ltd.
    Inventors: Idit Shachar, Liat Flaishon
  • Method and pharmaceutical composition for treating inflammation
    Patent number: 7354575
    Abstract: A method of treating an inflammation in a subject in need thereof is disclosed. The method comprises locally or systemically administering to the subject IFN-gamma in an amount so as to achieve an IFN-gamma bulk tissue concentration at a site of inflammation of 1-8,000 units per kilogram body weight, thereby ameliorating the inflammation.
    Type: Grant
    Filed: March 28, 2005
    Date of Patent: April 8, 2008
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Idit Shachar, Liat Flaishon
  • Method and pharmaceutical composition for treating inflammation
    Publication number: 20050169887
    Abstract: A method of treating an inflammation in a subject in need thereof is disclosed. The method comprises locally or systemically administering to the subject IFN-gamma in an amount so as to achieve an IFN-gamma bulk tissue concentration at a site of inflammation of 1-8,000 units per kilogram body weight, thereby ameliorating the inflammation.
    Type: Application
    Filed: March 28, 2005
    Publication date: August 4, 2005
    Inventors: Idit Shachar, Liat Flaishon
  • Method and pharmaceutical composition for treating inflammation
    Patent number: 6911198
    Abstract: A method of treating an inflammation in a subject in need thereof is disclosed. The method comprises locally or systemically administering to the subject IFN-? in an amount so as to achieve an IFN-? bulk tissue concentration at a site of inflammation of 1-8,000 units per kilogram body weight, thereby ameliorating the inflammation.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: June 28, 2005
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Idit Shachar, Liat Flaishon
  • Method and pharmaceutical composition for treating inflammation
    Publication number: 20030053985
    Abstract: A method of treating an inflammation in a subject in need thereof is disclosed. The method comprises locally or systemically administering to the subject IFN-&ggr; in an amount so as to achieve an IFN-&ggr; bulk tissue concentration at a site of inflammation of 1-8,000 units per kilogram body weight, thereby ameliorating the inflammation.
    Type: Application
    Filed: September 17, 2001
    Publication date: March 20, 2003
    Applicant: Yeda Research And Development Co. Ltd.
    Inventors: Idit Shachar, Liat Flaishon